Journal of Molecular Biology
Volume 96, Issue 1, 25 July 1975, Pages 47-54, IN3, 55-68
Journal home page for Journal of Molecular Biology

Comparison of viral RNA sequences in adenovirus 2-transformed and lytically infected cells

https://doi.org/10.1016/0022-2836(75)90181-3Get rights and content

Abstract

The complementary strands of fragments of 32P-labelled adenovirus 2 DNA generated by cleavage with restriction endonucleases EcoRI or Hpa1 were separated by electrophoresis. Saturation hybridization reactions were performed between these fragment strands and unlabelled RNA extracted from the cytoplasm of adenovirus 2-transformed rat embryo cells or from human cells early after adenovirus 2 infection. The fraction of each fragment strand complementary to RNA from these sources was measured by chromatography on hydroxylapatite. Maps of the viral DNA sequences complementary to messenger RNA in different lines of transformed cells and early during lytic infection of human cells were constructed.

Five lines of adenovirus 2-transformed cells were examined. All contained the same RNA sequences, complementary to about 10% of the light strand of EcoRI fragment A. DNA sequences coding for this RNA were more precisely located using Hpa1 fragments E and C and mapped at the left-hand end of the genome. Thus any viral function expressed in all adenovirus 2-transformed cells, tumour antigen, for example, must be coded by this region of the viral genome. Two lines, F17 and F18, express only these sequences; two others, 8617 and REM, also contain mRNA complementary to about 7% of the heavy strand of the right-hand end of adenovirus 2 DNA; a fifth line, T2C4, contains these and many additional viral RNA sequences in its cytoplasm.

The viral RNA sequences found in all lines of transformed cells are also present in the cytoplasm of human cells during the early phase of a lytic adenovirus infection. The additional cytoplasmic sequences in the 8617 and REM cell lines also correspond to “early” RNA sequences.

References (55)

  • W. Doerfler

    Virology

    (1969)
  • P.H. Gallimore et al.

    J. Mol. Biol

    (1974)
  • M. Green et al.

    Virology

    (1963)
  • G.S. Hayward

    Virology

    (1972)
  • J.T. Parsons et al.

    Virology

    (1971)
  • U. Pettersson et al.

    J. Mol. Biol

    (1973)
  • U. Pettersson et al.

    Virology

    (1967)
  • J. Sambrook et al.

    J. Mol. Biol

    (1972)
  • P.A. Sharp et al.

    J. Mol. Biol

    (1974)
  • H. Shimojo et al.

    Virology

    (1968)
  • D.C. Thomas et al.

    Virology

    (1969)
  • C. Tibbetts et al.

    J. Mol. Biol

    (1974)
  • A.R. Dunn et al.

    Int. J. Cancer

    (1973)
  • H. Eagle

    Soc. Exp. Biol. Med

    (1955)
  • S.J. Flint et al.
  • S.J. Flint et al.

    J. Virol

    (1975)
  • A.E. Freeman et al.
  • A.E. Freeman et al.
  • K. Fujinaga et al.
  • P.H. Gallimore
  • P.H. Gallimore

    J. Gen. Virol

    (1974)
  • R.V. Gilden et al.

    Nature (London)

    (1968)
  • Z. Gilead et al.

    J. Bacteriol

    (1965)
  • F.L. Graham et al.

    Nature (London)

    (1974)
  • M. Green et al.
  • T. Grodzicker et al.
  • J. Hedgepeth et al.
  • Cited by (0)

    One of us (P. H. G.) was partly supported during his stay at Cold Spring Harbor by a short-term fellowship from the British Cancer Research Campaign. Another author (S. J. F.) was supported by a fellowship from the Science Research Council of Great Britain. This work was paid for by the National Cancer Institute (grant no. CA13106-03).

    Present address: Center for Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Mass. 02139, U.S.A.

    View full text